Imvax Company

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

Total Funding: 166694660
Headquarters: Philadelphia, Pennsylvania, United States
Funding Status: Late Stage Venture
Employee Number: 11-50
Estimated Revenue: Less than $1M
Last Funding Type: Series C
Last Funding Date: 2020-07-16
Investors Number: 6
Founded Date: 2015-01-01
Industry: Whole-Cell Antigens